# Unimed Technology(Beijing)Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/unimed-technology-beijing-co

- Industry: Software
- Headquarters: Beijing, China
- Website: www.tongxinyilian.com
- Total disclosed funding: $21M
- Latest round: Series D (May 31, 2022)
- Investors on record: 6

## About

Based in Beijing, China, and established in 2014, Unimed Technology(Beijing)Co., Ltd. previous named Tongxin Yilian Technology (Beijing) Co., Ltd. is a health technology company that focuses on brain diseases. The company is a joint venture that was established by Tsinghua University School of Economics and Management Globalization Research Center and Tsinghua Medical Innovation Alliance. Meantime, the company established cooperation with the Department of Computer Science, Tsinghua University. The company's products covered 26 provinces, over 500 image centers and healthcare institutions, and accumulated 330,000 patients serviced. 

The company provides artificial intelligence (AI) health products. Specific products include aneurysm artificial intelligence surgical planning reports, neurodegenerative disease analysis reports, carotid plaque professional assessment reports, and brain tumor AI surgical planning reports. The company's business scope includes Unimed Brain Science medical technology R&D platform, Unimed Neosoph AI product Transformation Platform, and Unimed Neosoph AI product Transformation Platform.

The company will use the Series D funding to establish the brain science diagnosis and treatment platform and promote product commercialization.

## Funding rounds

- Series D, May 31, 2022 — China Merchants Capital, Beijing Bojia Private Equity Fund Management Co., Ltd.
- Series C, Jan 22, 2018 — CCB Investment Funds Management
- Series B, Aug 1, 2016, $11M — Legend Capital, Legend Star, MPC
- Series A, Sep 15, 2015, $10M — Legend Capital, Legend Star, MPC
- Angel, Nov 1, 2014 — Legend Star

## Investors

- Legend Star (https://capitalatlas.ai/funds/legend-star) — Angel, Series A, Series B
- Legend Capital — Series A, Series B
- MPC — Series A, Series B
- CCB Investment Funds Management (https://capitalatlas.ai/funds/ccb-investment-funds-management) — Series C
- China Merchants Capital (https://capitalatlas.ai/funds/china-merchants-capital) — Series D
- Beijing Bojia Private Equity Fund Management Co., Ltd. — Series D